Structures by: Ding W. L.
Total: 17
C61H55N5O2S
C61H55N5O2S
Materials Chemistry Frontiers (2019) 3, 1 151
a=13.5619(9)Å b=13.7951(10)Å c=15.3779(11)Å
α=110.309(2)° β=101.188(2)° γ=97.849(2)°
5-Bromo-2-iodopyrimidine
C4H2BrIN2
Acta Crystallographica Section E (2006) 62, 10 o4238-o4239
a=6.1410(12)Å b=6.7890(14)Å c=16.071(3)Å
α=90.00° β=90.00° γ=90.00°
N-(2,6-Dimethylphenyl)-2-[2-(3-phenyl-1,2,4-oxadiazol-5-yl)phenoxy]acetamide
C24H21N3O3
Acta Crystallographica Section E (2006) 62, 11 o4950-o4951
a=12.685(3)Å b=20.073(4)Å c=8.3090(17)Å
α=90.00° β=102.87(3)° γ=90.00°
2-[3-(4-Chlorophenyl)-1,2,4-oxadiazol-5-yl]phenol
C14H9ClN2O2
Acta Crystallographica Section E (2006) 62, 12 o5592-o5593
a=6.3900(13)Å b=5.0380(10)Å c=19.255(4)Å
α=90.00° β=97.98(3)° γ=90.00°
N-(2,6-Dimethylphenyl)-2-{2-[3-(3-methoxyphenyl)-1,2,4-oxadiazol- 5-yl]phenoxy}acetamide
C25H23N3O4
Acta Crystallographica Section E (2006) 62, 12 o5574-o5575
a=8.0360(16)Å b=11.692(2)Å c=12.780(3)Å
α=66.93(3)° β=85.56(3)° γ=81.18(3)°
2-[3-(4-Methylphenyl)-1,2,4-oxadiazol-5-yl]phenol
C15H12N2O2
Acta Crystallographica Section E (2006) 62, 12 o5840-o5841
a=6.5110(13)Å b=5.1720(10)Å c=18.763(4)Å
α=90.00° β=99.14(3)° γ=90.00°
2-Chlorobenzamide oxime monohydrate
C7H7ClN2O,H2O
Acta Crystallographica Section E (2007) 63, 2 o1019-o1020
a=4.5550(9)Å b=6.8790(14)Å c=28.715(6)Å
α=91.37(3)° β=90.58(3)° γ=101.21(3)°
6,6'-Bis(2H-1,2,3-benzotriazol-2-yl)-4,4'-bis(2,4,4-trimethylpentan-2-yl)- 2,2'-methylenebiphenol
C41H50N6O2
Acta Crystallographica Section E (2007) 63, 2 o819-o820
a=18.302(4)Å b=8.0960(16)Å c=24.553(5)Å
α=90.00° β=90.00° γ=90.00°
2-Methylbenzamidoxime
C8H10N2O
Acta Crystallographica Section E (2007) 63, 2 o487-o488
a=9.751(2)Å b=7.0880(14)Å c=11.982(2)Å
α=90.00° β=98.60(3)° γ=90.00°
4-Nitrobenzamidoxime
C7H7N3O3
Acta Crystallographica Section E (2007) 63, 2 o489-o490
a=11.320(2)Å b=7.7760(16)Å c=18.802(4)Å
α=90.00° β=90.00° γ=90.00°
N-(2,6-dimethylphenyl)-2-(2-oxopyrrolidin-1-yl)acetamide
C14H18N2O2
Acta Crystallographica Section E (2006) 62, 9 o3838-o3839
a=6.3390(13)Å b=9.3130(19)Å c=22.712(5)Å
α=90.00° β=90.00° γ=90.00°
2-{2-[3-(4-Chlorophenyl)-1,2,4-oxadiazol-5-yl]phenoxy}- N-(2,6-dimethylphenyl)acetamide
C24H20ClN3O3
Acta Crystallographica Section E (2006) 62, 10 o4744-o4745
a=12.498(3)Å b=8.2410(16)Å c=20.996(4)Å
α=90.00° β=93.21(3)° γ=90.00°
N-(2,6-Dimethylphenyl)-2-(2-{3-[4-(methylsulfanyl)phenyl]-1,2,4-oxadiazol- 5-yl}phenoxy)acetamide
C25H23N3O3S
Acta Crystallographica Section E (2007) 63, 4 o1683-o1684
a=8.6160(17)Å b=9.2900(19)Å c=15.225(3)Å
α=84.34(3)° β=81.45(3)° γ=66.66(3)°
4-(Methylsulfanyl)benzamide oxime
C8H10N2OS
Acta Crystallographica Section E (2007) 63, 4 o1834-o1835
a=10.221(2)Å b=11.882(2)Å c=17.120(3)Å
α=74.12(3)° β=72.91(3)° γ=64.94(3)°
N-(2,6-Dimethylphenyl)-2-{2-[3-(4-fluorophenyl)-1,2,4-oxadiazol- 5-yl]phenoxy}acetamide
C24H20FN3O3
Acta Crystallographica Section E (2007) 63, 5 o2062-o2063
a=12.143(2)Å b=8.1850(16)Å c=20.942(4)Å
α=90.00° β=90.52(3)° γ=90.00°
2-{2-[3-(2-Chlorophenyl)-1,2,4-oxadiazol-5-yl]phenoxy}- N-(2,6-dimethylphenyl)acetamide
C24H20ClN3O3
Acta Crystallographica Section E (2006) 62, 11 o5280-o5281
a=8.9110(18)Å b=10.612(2)Å c=12.491(3)Å
α=94.55(3)° β=92.09(3)° γ=114.63(3)°
2-(2H-1,2,3-Benzotriazol-2-yl)-4-(2,4,4-trimethylpentan-2-yl)phenol
C20H25N3O
Acta Crystallographica Section E (2007) 63, 1 o49-o50
a=13.177(3)Å b=16.289(3)Å c=8.4280(17)Å
α=90.00° β=90.00° γ=90.00°